Technical Analysis for FEMY - Femasys Inc.
| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Up | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Bearish Engulfing | Bearish | -10.06% | |
| Bollinger Band Squeeze | Range Contraction | -10.06% | |
| BB Squeeze + Upper Band Touch | Range Contraction | -10.06% | |
| Upper Bollinger Band Touch | Strength | -10.06% | |
| Non-ADX 1,2,3,4 Bearish | Bearish Swing Setup | -11.96% | |
| Bollinger Band Squeeze | Range Contraction | -11.96% | |
| BB Squeeze + Upper Band Touch | Range Contraction | -11.96% | |
| Above Upper BB | Strength | -11.96% | |
| Gapped Up | Strength | -11.96% | |
| Up 3 Days in a Row | Strength | -11.96% |
| Alert | Time |
|---|---|
| Down 10% | about 3 hours ago |
| Down 1 ATR | about 3 hours ago |
| 60 Minute Opening Range Breakdown | about 4 hours ago |
| Fell Below 20 DMA | about 4 hours ago |
| Fell Below 10 DMA | about 4 hours ago |
Free Daily (Stock) Chart Reading
- Earnings date: 05/09/2024
Femasys Inc. Description
Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel solutions and next-generation advancements providing significant clinical impact to address severely underserved areas. With an initial focus in the area of reproductive health, its two lead product candidates offer solutions to improve patient care and health economics: FemBloc, a first and only non-surgical product for permanent birth control and FemaSeed, a first and only directed sperm delivery product for infertility treatment. Femasys’ FemVue product for fallopian tube assessment by ultrasound is currently marketed in the United States as its main commercial priority. Femasys has also developed a novel technology platform for tissue sampling intended to be marketed alongside our other women-specific medical products in the physician’s office setting.
Classification
Sector: Healthcare
Industry: Medical Instruments & Supplies
Keywords: Ultrasound Infertility Birth Control Fertility Medicine Assisted Reproductive Technology
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 4.75 |
| 52 Week Low | 0.2479 |
| Average Volume | 640,111 |
| 200-Day Moving Average | 1.12 |
| 50-Day Moving Average | 1.60 |
| 20-Day Moving Average | 1.32 |
| 10-Day Moving Average | 1.32 |
| Average True Range | 0.12 |
| RSI (14) | 49.75 |
| ADX | 22.65 |
| +DI | 19.86 |
| -DI | 18.83 |
| Chandelier Exit (Long, 3 ATRs) | 1.27 |
| Chandelier Exit (Short, 3 ATRs) | 1.57 |
| Upper Bollinger Bands | 1.41 |
| Lower Bollinger Band | 1.23 |
| Percent B (%b) | 0.9 |
| BandWidth | 13.54 |
| MACD Line | -0.05 |
| MACD Signal Line | -0.07 |
| MACD Histogram | 0.0213 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.60 | ||||
| Resistance 3 (R3) | 1.62 | 1.56 | 1.57 | ||
| Resistance 2 (R2) | 1.56 | 1.51 | 1.56 | 1.55 | |
| Resistance 1 (R1) | 1.48 | 1.48 | 1.45 | 1.46 | 1.54 |
| Pivot Point | 1.42 | 1.42 | 1.41 | 1.42 | 1.42 |
| Support 1 (S1) | 1.34 | 1.37 | 1.31 | 1.32 | 1.24 |
| Support 2 (S2) | 1.28 | 1.34 | 1.28 | 1.23 | |
| Support 3 (S3) | 1.20 | 1.28 | 1.22 | ||
| Support 4 (S4) | 1.18 |
